ClearPoint Neuro (CLPT) Cost of Revenue (2011 - 2026)

ClearPoint Neuro (CLPT) has 15 years of Cost of Revenue data on file, last reported at $4.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 30.39% year-over-year to $4.4 million; the trailing twelve-month figure through Mar 2026 stood at $15.3 million (up 22.32% YoY), and the FY2025 full-year result was $14.3 million, up 16.39% from the prior year.
• Cost of Revenue rose to $4.4 million in Q1 2026, from $4.0 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $4.4 million in Q1 2026 to a low of $1.5 million in Q3 2022.
• A 5-year average of $2.8 million and a median of $2.9 million in 2024 frame the typical range for Cost of Revenue.
• Peak annual rise in Cost of Revenue reached 70.76% in 2022, while the deepest fall reached 4.31% in 2022.
• Tracing CLPT's Cost of Revenue over 5 years: stood at $1.8 million in 2022, then jumped by 54.7% to $2.8 million in 2023, then rose by 7.58% to $3.0 million in 2024, then surged by 33.13% to $4.0 million in 2025, then climbed by 9.14% to $4.4 million in 2026.
• Business Quant data shows CLPT's Cost of Revenue at $4.4 million in Q1 2026, $4.0 million in Q4 2025, and $3.3 million in Q3 2025.